ask="4.46"
ask_size="200"
average_daily_volume="561673"
bid="4.05"
bid_size="400"
book_value="2.30"
change="+0.11"
change_from_200_day_moving_average="-0.46"
change_from_50_day_moving_average="-0.15"
change_from_52_week_high="-2.55"
change_From_52_week_low="1.15"
change_in_percent="+2.66%"
close="4.25"
dividend_pay_date="12/30/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.68"
ebitda="-43.09M"
eps_estimate_current_year="-1.47"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.84"
ex_dividend_date="12/31/2013"
float_shares="40197000"
high="4.28"
high_52_weeks="6.80"
last_trade_date="2/8/2017"
last_trade_price="4.25"
last_trade_size="3611"
last_trade_time="4:00pm"
low="4.06"
low_52_weeks="3.10"
market_capitalization="278.06M"
moving_average_200_day="4.71"
moving_average_50_day="4.40"
name="Aralez Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="8.75"
open="4.09"
pe_ratio="N/A"
peg_ratio="-0.09"
percent_change_from_200_day_moving_average="-9.85%"
percent_change_from_50_day_moving_average="-3.32%"
percent_change_from_52_week_high="-37.50%"
percent_change_from_52_week_low="+37.10%"
previous_close="4.14"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.80"
price_per_sales="6.73"
revenue="40.23M"
shares_outstanding="65427000"
short_ratio="6.30"
stock_exchange="NMS"
symbol="ARLZ"
volume="254451"
weeks_range_52="3.10 - 6.80"
